Emyria Limited (ASX: EMD)
Australia
· Delayed Price · Currency is AUD
0.0360
0.00 (0.00%)
Dec 20, 2024, 10:02 AM AEST
Emyria Revenue
In the fiscal year ending June 30, 2024, Emyria had annual revenue of 2.20M AUD with 38.32% growth. Emyria had revenue of 1.11M in the half year ending June 30, 2024, with 7.04% growth.
Revenue
2.20M
Revenue Growth
+38.32%
P/S Ratio
5.87
Revenue / Employee
n/a
Employees
n/a
Market Cap
14.95M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
CSL Limited | 22.18B |
ResMed Inc. | 6.93B |
Pro Medicus Limited | 161.50M |
Fisher & Paykel Healthcare Corporation Limited | 1.74B |
Cochlear Limited | 2.24B |
Sonic Healthcare Limited | 8.97B |
Telix Pharmaceuticals Limited | 645.68M |
Ramsay Health Care Limited | 16.66B |